Skip to main content
Novartis AG
Healthcare · Drug Manufacturers - General
Made on Aug 23, 2026
Price at call $158.86
6-month call Bull +8.9%
Target by Feb 2027 $173.00
Great value below $145.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change +8.9% to $173.00
Predicted High $173.00 at 6 months
Predicted Low $160.20 in 2 weeks

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 23, 2026 1:02 pm
Bull NVS trends higher to $173.00 (+8.9% from $158.86) by Feb 2027. dip-then-recover
ThesisNVS trades below composite fair value with modest quality support, a calm risk-on tape, and positive cardiovascular data providing near-term lift. Value gravity toward $170-175 dominates over months, with the deterministic baseline reasonable but slight upside skew from signal-adjusted anchors.
Invalidated ifBreak below $145 on heavy volume or regime flip to risk-off with sector rotation out of defensives
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $158.86 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 23, 2026 $158.86 at call The anchor — every point below is measured from this price and date.
2 weeks Sep 6, 2026 $150.71–$167.01 typical range · internal point $160.20 ±5.1% 6/10 Risk-on tape and cardio data momentum carry lift
1 month Sep 23, 2026 $147.05–$170.67 typical range · internal point $161.50 ±7.4% 6/10 Sentiment tailwind persists, drift toward fair value
2 months Oct 23, 2026 $163.75 +3.1% 5/10 Value gravity engages, defensive bid steady
3 months Nov 23, 2026 $166.50 +4.8% 5/10 Anchored PE zone approached, slow grind higher
4 months Dec 23, 2026 $169.00 +6.4% 5/10 Year-end defensive rotation supports low-beta name
5 months Jan 23, 2027 $171.50 +8.0% 4/10 Approaching composite fair value plus DCF pull
6 months Feb 23, 2027 $173.00 +8.9% 4/10 Convergence near baseline endpoint, upside capped near-term

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $173.71 (+9.3%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$158.86
Composite fair value$161.98
Signal-adjusted fair value$216.25
DCF fair value$196.94
Anchored-PE fair value$168.29
Buy-below (value lens)$145.00
Value net score+3
Value confidence6 / 10
Quality net score+59
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 23.2%  3m 25.7%  6m 23.9%  
Daily σ (realism noise)1.6%
Beta vs S&P 500 1m -0.02  3m -0.14  5m 0.19  
Trailing 6-month return-2.3%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jul 30, 2026 23d behind NVS-20260730-203014-f2ab
ext-forensic-memo Aug 22, 2026 freshest ext-NVS-20260822-141324-56fd
ext-lens-quality Aug 22, 2026 freshest ext-NVS-20260822-141324-56fd
ext-lens-sentiment Aug 22, 2026 freshest ext-NVS-20260822-141324-56fd
ext-lens-value Aug 22, 2026 freshest ext-NVS-20260822-141324-56fd
scenario-valuation Aug 23, 2026 freshest NVS-20260822-135549-2627
valuation-synthesis Aug 23, 2026 freshest NVS-20260822-135549-2627

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 23, 2026 v0.6.0 Bull $158.86 $173.00 +8.9% Feb 2027 viewing
Jul 31, 2026 v0.6.0 Bull $158.44 $172.50 +8.9% Jan 2027 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.